Clinical trials
Recruiting Atherosclerosis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Inno Medicine Co., Ltd. | 2 |
| CSL Behring | 2 |
| Amgen | 1 |
| AstraZeneca | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Eli Lilly and Company | 1 |
| Fudan University | 1 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 1 |
| Hudson Biotech | 1 |
| ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 19 |
| Coronary Artery Disease | 4 |
| Cardiovascular Diseases | 3 |
| Acute Coronary Syndrome | 2 |
| Diabetes Mellitus | 2 |
| Kidney Failure, Chronic | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Coronary Disease | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Dyslipidemias | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.